NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Allergic Conjunctivitis


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
2009 NOV 16 ... ophthalmic solution is indicated for temporary relief of ocular itching due to seasonal allergic conjunctivitis. Ketorolac tromethamine ophthalmic solution is also indicated for the treatment of ...
Subject: Ophthalmic Solution
Price: $3.00
*
CombinatoRx Reports Financial Results for the Third Quarter 2009
2009 NOV 16 ... alliances. Positive clinical results with Prednisporin in subjects with persistent allergic conjunctivitis were recently announced and based on this data; further advanced clinical trials for ...
Subject: CombinatoRx, Incorporated
Price: $3.00
*
CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals
2009 OCT 19 ... Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis. "We are pleased to see that a CombinatoRx-derived combination drug ...
Subject: CombinatoRx, Incorporated
Price: $3.00
*
Data on pediatric immunology detailed by T. Kusunoki and co-authors
2009 NOV 28 ... school age, the prevalence of bronchial asthma, atopic dermatitis, allergic rhinitis and allergic conjunctivitis were significantly higher in this group. Moreover, avoidance of other foods (buckwheat, ...
Subject: Pediatric Immunology
Price: $3.00
*
Fovea Pharmaceuticals to be Acquired by sanofi-aventis
2009 OCT 12 ... of prednisolone and cyclosporine, currently in phase II for the treatment of persistent allergic conjunctivitis, FOV 2302, an intravitreal formulation of a plasma kallikrein inhibitor, in phase I for ...
Subject: Pharmaceuticals
Price: $3.00
*
Inspire's President and CEO Christy Shaffer Receives Cystic Fibrosis Foundation's Highest Award
2009 NOV 2 ... the co-promotion of Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of Restasis® (cyclosporine ophthalmic emulsion) ...
Subject: Inspire Pharmaceuticals, Inc.
Price: $3.00
*
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
2009 NOV 23 ... Severe Itching Response in a Conjunctival Allergen Challenge (CAC) Clinical Model of Allergic Conjunctivitis," integrated results from two Phase 3 studies demonstrated Bepreve 1.5% was as ...
Subject: Allergies
Price: $3.00
*
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting
2009 NOV 2 ... (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for ...
Subject: Pharmaceuticals
Price: $3.00
*
ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
2009 NOV 16 ... approval to begin marketing Bepreve, a new treatment for ocular itching associated with allergic conjunctivitis. We immediately launched Bepreve, by making the decision to add over 60 new sales ...
Subject: Pharmaceuticals
Price: $3.00
*
New allergies study findings have been published by scientists at Emory University, Medical Department
2009 NOV 23 ... According to a study from the United States, "Allergic conjunctivitis is characterized by allergen-specific IgE in the serum and infiltration of eosinophils ...
Subject: Allergies
Price: $3.00
*
New keratoconjunctivitis study results reported from Juntendo University, Medical Department
2009 OCT 5 ... Study of Novel Cyclosporine 0.1% Aqueous Ophthalmic Solution in the Treatment of Severe Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics, 2009;25(4):365-371). For ...
Subject: Keratoconjunctivitis
Price: $3.00
*
New stem cell research data have been reported by K.F. Tabbara and co-authors
2009 OCT 12 ... glaucoma, cytomegalovirus retinitis, fungal endophthalmitis, and acquisition of allergic conjunctivitis from atopic donors. There was no correlation between the pattern of ocular complications ...
Subject: Stem Cell Research
Price: $3.00
*
Reports from Kyoto Prefectural University, Medical Department add new data to research in allergies
2009 NOV 16 ... to be a specific ligand for ST2L. The authors investigated the role of IL-33 in chronic allergic conjunctivitis. Immunohistochemical analysis was carried out using giant papillae samples obtained from ...
Subject: Allergies
Price: $3.00
*
Research in the area of atopic dermatitis reported from M. Komine and colleagues
2009 OCT 5 ... "Atopic dermatitis frequently accompanies bronchial asthma, allergic rhinitis, and allergic conjunctivitis, the pathogenesis of which has frequently focused on the immunological aspects; however, ...
Subject: Atopic Dermatitis
Price: $3.00
*
Scientists at Creighton University publish research in rhinoconjunctivitis
2009 NOV 23 ... NY 10010-1710, USA. Keywords: City:Omaha, State:NE, Country:United States, Allergic Conjunctivitis, Allergic Rhinitis, Allergies, Allergy Medicine, Asthma, Clinical Immunology, Clinical ...
Subject: Rhinoconjunctivitis
Price: $3.00
*
Scientists at Osaka University, Medical Department describe research in allergies
2009 SEP 28 ... effective antiallergic agent, inhibits various clinical symptoms of allergic rhinitis, allergic conjunctivitis, urticaria, allergic dermatitis, pruritus cutaneous, and prurigo. In addition to greater ...
Subject: Allergies
Price: $3.00
*
Scientists at University of Tokyo, Department of Ophthalmology describe research in allergies
2009 OCT 13 ... 'Relationship between myopia and allergen-specific serum IgE levels in patients with allergic conjunctivitis,' is now available. "Various exogenous allergens can cause...
Subject: Allergies
Price: $3.00
*
Studies from University of Naples yield new data on allergies
2009 OCT 12 ... study was to evaluate in a large series the incidence of latent infection during chronic allergic conjunctivitis. In a 5-year follow-up prospective, nonrandomized trial, we evaluated 236 patients (472 ...
Subject: Allergies
Price: $3.00
*
Study results from D. Shii and colleagues in the area of allergies published
2009 OCT 5 ... of cyclosporine A eye drops on the early-phase reaction were investigated in a type-I allergic conjunctivitis model. Mice were actively sensitized with ragweed (RW) absorbed on aluminium hydroxide ...
Subject: Allergies
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login